Discontinuation report MEDROXY-5
Report ID | 120557 |
Drug Identification Number | 02253577 |
Brand name | MEDROXY-5 |
Common or Proper name | MEDROXY |
Company Name | PRO DOC LIMITEE |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MEDROXYPROGESTERONE ACETATE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | G03DA |
ATC description | PROGESTOGENS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-08-31 |
Actual discontinuation date | 2020-08-20 |
Remaining supply date | 2021-01-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-08-21 | English | Compare |
v4 | 2020-08-20 | French | Compare |
v3 | 2020-08-20 | English | Compare |
v2 | 2020-07-17 | French | Compare |
v1 | 2020-07-17 | English | Compare |
Showing 1 to 5 of 5